The in-vitro activity of SQ 82,291, a new monobactam, in comparison with aztreonam. 1986

J A García-Rodríguez, and J E García-Sánchez, and A Plata, and I Trujillano

The in-vitro activity of a new monobactam antibiotic, SQ 82,291, was compared with that of aztreonam against 529 strains of aerobic and facultatively anaerobic bacteria. SQ 82,291, which is absorbed orally when administered as an ester, has shown good activity against different bacteria of the family Enterobacteriaceae and Haemophilus influenzae. The susceptibility of SQ 82,291 is lower than that to aztreonam in the species that were sensitive and SQ 82,291 showed no activity at all against staphylococci and strict anaerobes (like aztreonam); unlike aztreonam SQ 82,291 was not effective against Pseudomonas aeruginosa.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008997 Monobactams Monocyclic, bacterially produced or semisynthetic beta-lactam antibiotics. They lack the double ring construction of the traditional beta-lactam antibiotics and can be easily synthesized. Antibiotics, Monobactam,Monobactam,Monocyclic beta-Lactam,Monocyclic beta-Lactams,beta-Lactams, Monocyclic,Monobactam Antibiotics,Monocyclic beta Lactam,Monocyclic beta Lactams,beta Lactams, Monocyclic,beta-Lactam, Monocyclic
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D001398 Aztreonam A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms. Az-threonam,Azactam,Azthreonam,SQ-26,776,Urobactam,Az threonam,SQ 26,776,SQ26,776
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria

Related Publications

J A García-Rodríguez, and J E García-Sánchez, and A Plata, and I Trujillano
April 1986, The New Zealand medical journal,
J A García-Rodríguez, and J E García-Sánchez, and A Plata, and I Trujillano
August 1983, Antimicrobial agents and chemotherapy,
J A García-Rodríguez, and J E García-Sánchez, and A Plata, and I Trujillano
April 1983, Antimicrobial agents and chemotherapy,
J A García-Rodríguez, and J E García-Sánchez, and A Plata, and I Trujillano
December 1981, The Journal of antimicrobial chemotherapy,
J A García-Rodríguez, and J E García-Sánchez, and A Plata, and I Trujillano
January 1985, Clinical pharmacy,
J A García-Rodríguez, and J E García-Sánchez, and A Plata, and I Trujillano
December 1981, The Journal of antimicrobial chemotherapy,
J A García-Rodríguez, and J E García-Sánchez, and A Plata, and I Trujillano
May 1987, Annals of internal medicine,
J A García-Rodríguez, and J E García-Sánchez, and A Plata, and I Trujillano
February 1985, The American journal of medicine,
J A García-Rodríguez, and J E García-Sánchez, and A Plata, and I Trujillano
May 1988, The Medical clinics of North America,
J A García-Rodríguez, and J E García-Sánchez, and A Plata, and I Trujillano
January 1983, Chemotherapy,
Copied contents to your clipboard!